Immune-mediated regression of ‘metastatic’ neuroblastoma in the liver
- 28 February 1994
- journal article
- research article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 29 (2), 155-160
- https://doi.org/10.1016/0022-3468(94)90310-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Establishment of animal liver metastatic model for C-1300 murine neuroblastoma and immunotherapy for it using OK-432, streptococcus preparationJournal of Surgical Research, 1992
- Heterogeneity of the lymphokine-activated killer cell phenotypeCellular Immunology, 1991
- Histological evidence of natural killer cell aggregation against malignant melanoma induced by adoptive immunotherapy with lymphokine-activated killer cellsThe Journal of Pathology, 1989
- The Influence of Natural Killer Cells in NeuroblastomaArchives of Surgery, 1989
- The Development of New Immunotherapies for the Treatment of Cancer Using Interleukin-2Annals of Surgery, 1988
- Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection.The Journal of Experimental Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Administration of slowly released recombinant interleukin 2 Augmentation of the efficacy of adoptive immunotherapy with lymphokine-activated killer (LAK) cellsJournal of Immunological Methods, 1986
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Regression of Neuroblastoma IV-S: A Genetic HypothesisNew England Journal of Medicine, 1980